These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26177641)

  • 1. Current Immunotherapies for Renal Cell Carcinoma.
    Al-Marrawi MY; Holder SL
    Curr Mol Pharmacol; 2016; 9(3):252-263. PubMed ID: 26177641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for renal cell cancer.
    Yang JC; Childs R
    J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review.
    Raman R; Vaena D
    Biomed Res Int; 2015; 2015():367354. PubMed ID: 26161397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of renal cell carcinoma.
    Gouttefangeas C; Stenzl A; Stevanović S; Rammensee HG
    Cancer Immunol Immunother; 2007 Jan; 56(1):117-28. PubMed ID: 16676181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel immunotherapeutic strategies in development for renal cell carcinoma.
    Inman BA; Harrison MR; George DJ
    Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic developments in renal cell cancer.
    Prenen H; Gil T; Awada A
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies.
    Thomas JS; Kabbinavar F
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):527-33. PubMed ID: 26299335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?
    Anselmo Da Costa I; Rausch S; Kruck S; Todenhöfer T; Stenzl A; Bedke J
    Expert Rev Anticancer Ther; 2017 Apr; 17(4):357-368. PubMed ID: 28162024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in kidney cancer: the past, present, and future.
    Hammers H
    Curr Opin Urol; 2016 Nov; 26(6):543-7. PubMed ID: 27533501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Checkpoint Blockade - a New Treatment Paradigm in Renal Cell Carcinoma.
    Grünwald V
    Oncol Res Treat; 2016; 39(6):353-8. PubMed ID: 27259695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy.
    Rausch S; Kruck S; Stenzl A; Bedke J
    Future Oncol; 2014 May; 10(6):937-48. PubMed ID: 24941980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of metastatic renal cell cancer.
    Fishman M; Seigne J
    Cancer Control; 2002; 9(4):293-304. PubMed ID: 12228755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in renal cell cancer immunotherapy.
    Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
    Expert Opin Biol Ther; 2007 May; 7(5):727-37. PubMed ID: 17477809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Landscape of Immunotherapy in Genitourinary Malignancies.
    Alhalabi O; Rafei H; Bilen MA; Shah AY
    Adv Exp Med Biol; 2020; 1244():107-147. PubMed ID: 32301013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current immunotherapeutic strategies in renal cell carcinoma.
    Amato RJ
    Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging immunotherapy in advanced renal cell carcinoma.
    Mendiratta P; Rini BI; Ornstein MC
    Urol Oncol; 2017 Dec; 35(12):687-693. PubMed ID: 28889919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell cancer: is immunotherapy dead?
    Wagstaff J
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix94-7. PubMed ID: 17631604
    [No Abstract]   [Full Text] [Related]  

  • 18. [The present state and the future perspective of immunotherapy of renal cell carcinoma].
    Kawashima H
    Nihon Rinsho; 2015 Jan; 73(1):167-74. PubMed ID: 25626324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory Therapies for Renal Cell Carcinoma.
    Liu M; Wu H; Shangguan D; Jiang Y; Li X; Liu S; Zhou B; Yin T; Gong Z
    Protein Pept Lett; 2018; 25(6):534-547. PubMed ID: 29848257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trials.
    Godwin JL; Zibelman M; Plimack ER; Geynisman DM
    Discov Med; 2014 Dec; 18(101):341-50. PubMed ID: 25549705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.